Tekla Life Sciences Inves...
13.46
0.18 (1.36%)
At close: Jan 15, 2025, 3:59 PM
13.49
0.19%
After-hours Jan 15, 2025, 04:10 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY98 FY97 FY96
Net Income 22.35M -104.60K 64.53K 123.05K -70.48K 28.66K 68.56K -11.91K 40.50K 89.27K 84.64K 77.63M 37.47M 10.19M -21.67M 60.25M 50.51M -21.44M 44.76M 7.16M 38.62M -50.41M -95.03M -30.38M 15.19M 21.81M
Depreciation & Amortization n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital n/a n/a n/a n/a n/a n/a n/a n/a n/a -4.86 984.65 n/a 114.10M -9.30M 26.30M 13.90M -5.20M -600.00K -3.50M -4.60M n/a n/a -2.80M n/a n/a -1.30M
Other Non-Cash Items -22.35M 104.60K -64.53K -123.05K 70.48K -28.66K -68.56K 11.91K -40.50K -141.77K -76.12K -56.53M -37.47M -10.19M 21.67M -60.25M -50.51M 21.44M -44.76M -7.16M -38.62M 50.41M 95.03M 30.38M -15.19M -21.81M
Deferred Income Tax n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital n/a n/a n/a n/a n/a n/a n/a n/a n/a -65.19 948.35 -24.83K 118.30M 1.90M 13.00M 11.80M -3.70M -2.10M -3.20M -3.20M -2.40M -2.60M -1.90M -1.70M -1.50M -1.50M
Operating Cash Flow n/a n/a -0.74 n/a -0.62 n/a n/a n/a n/a -52.57K 9.47K 21.11M 118.30M 1.90M 13.00M 11.80M -3.70M -2.10M -3.20M -3.20M -2.40M -2.60M -1.90M -1.70M -1.50M -1.50M
Capital Expenditures n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 14.30M -58.20M 9.80M 8.50M 9.30M 9.60M 10.20M 2.00M 7.80M 500.00K
Investing Cash Flow n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 14.30M -58.20M 9.80M 8.50M 9.30M 9.60M 10.20M 2.00M 7.80M 500.00K
Debt Repayment n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -10.88M -107.10M -3.80M n/a n/a n/a 71.40M n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a -13.96K -9.44K -10.23M -11.20M -3.60M -7.60M -11.80M -10.60M -11.10M -7.30M -5.70M -5.90M -7.20M -8.10M -1.60M -6.30M n/a
Other Financial Acitivies n/a n/a n/a n/a n/a n/a n/a n/a n/a 66.49K n/a -10.88M -107.10M -3.70M n/a n/a n/a 71.40M n/a n/a n/a n/a n/a n/a n/a n/a
Financial Cash Flow n/a n/a n/a n/a n/a n/a n/a n/a n/a 52.53K -9.44K -21.10M -118.30M -7.30M -7.60M -11.80M -10.60M 60.30M -7.30M -5.70M -5.90M -7.20M -8.10M -1.60M -6.30M n/a
Net Cash Flow 32.00 -545 -0.74 n/a 1.12M n/a n/a n/a n/a -34.24 35.89 117.00 n/a -5.40M 5.40M n/a n/a n/a -700.00K -400.00K 1.00M -200.00K 300.00K -1.30M -100.00K -1.00M
Free Cash Flow n/a n/a -0.74 n/a -0.62 n/a n/a n/a n/a -52.57K 9.47K 21.11M 118.30M 1.90M 13.00M 11.80M -3.70M -2.10M -3.20M -3.20M -2.40M -2.60M -1.90M -1.70M -1.50M -1.50M